Followers | 273 |
Posts | 55457 |
Boards Moderated | 24 |
Alias Born | 08/29/2007 |
Friday, August 18, 2023 12:38:26 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent MNPR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 11:45:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 11:44:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 12:00:10 PM
- Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr • GlobeNewswire Inc. • 09/12/2024 12:00:00 PM
- Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:07:29 PM
- Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule • GlobeNewswire Inc. • 08/27/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 12:00:13 PM
- Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers • GlobeNewswire Inc. • 08/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 12:00:10 PM
- Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr • GlobeNewswire Inc. • 08/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 12:02:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 12:01:37 PM
- Monopar Therapeutics Announces 1-for-5 Reverse Stock Split • GlobeNewswire Inc. • 08/09/2024 12:00:00 PM
- Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments • GlobeNewswire Inc. • 08/09/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 07/22/2024 11:01:16 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/22/2024 11:00:07 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/11/2024 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:01:43 PM
- Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr • GlobeNewswire Inc. • 07/09/2024 11:00:00 AM
- Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24 • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 10:08:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 11:30:32 AM
- Monopar and NorthStar Amend & Extend Collaboration • GlobeNewswire Inc. • 06/11/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 12:00:17 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM